Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,533 | 3,701 | 4,288 | 7,218 | 14,428 |
| Marketable Securities | 248 | 4,182 | 7,391 | 8,132 | 8,137 |
| Receivables | 94 | 28 | 6 | 45 | 23 |
| Inventories | 0 | 0 | 0 | 1,300 | 842 |
| Other current assets | 274 | 531 | 539 | 3,324 | 343 |
| TOTAL | $4,149 | $8,442 | $12,223 | $20,018 | $23,772 |
| Non-Current Assets | |||||
| PPE Net | 5,427 | 5,695 | 5,695 | 5,617 | 5,517 |
| Other Non-Current Assets | 561 | 1,155 | 250 | 250 | 609 |
| TOTAL | $5,988 | $6,849 | $5,945 | $5,867 | $6,126 |
| Total Assets | $5,304 | $10,233 | $13,414 | $23,401 | $27,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 113 | 138 | 153 | 132 | 186 |
| Accounts payable and accrued liabilities | 131 | 735 | 884 | 1,288 | 1,351 |
| Accrued Expenses | 1,312 | 2,179 | 1,446 | 1,329 | 851 |
| TOTAL | $1,556 | $3,052 | $2,484 | $2,748 | $2,388 |
| Non-Current Liabilities | |||||
| Long Term Debt | 221 | 248 | 277 | 334 | 321 |
| TOTAL | $221 | $248 | $277 | $337 | $325 |
| Total Liabilities | $1,777 | $3,299 | $2,761 | $3,085 | $2,713 |
| Shareholders' Equity | |||||
| Common Shares | 3,510 | 3,509 | 3,508 | 3,508 | 3,497 |
| Retained earnings | -116,679 | -113,339 | -109,512 | -99,660 | -94,659 |
| Other shareholders' equity | 0 | -176 | -266 | -379 | -503 |
| TOTAL | $3,527 | $6,933 | $10,653 | $20,316 | $24,957 |
| Total Liabilities And Equity | $5,304 | $10,233 | $13,414 | $23,401 | $27,670 |